Balance Sheet Details
|9 Months Ended|
Sep. 30, 2022
|Balance Sheet Related Disclosures [Abstract]|
|Balance Sheet Details||Balance Sheet Details
Cash, cash equivalents and restricted cash consist of the following:
As of September 30, 2022 and December 31, 2021, cash and cash equivalents included money market funds of approximately $0.4 million and $20.4 million, respectively. As of September 30, 2022 and December 31, 2021, the Company had restricted cash of approximately $1.0 million and $1.2 million, respectively. The cash is restricted in connection with guarantees for certain import duties and office leases.
Inventory consists of the following:
Property and equipment, net consists of the following:
Depreciation expense for the three months ended September 30, 2022 and 2021 was $5.1 million and $4.7 million, respectively. Depreciation expense for the nine months ended September 30, 2022 and 2021 was $14.7 million and $12.0 million, respectively.
In March 2022, the Company entered into a note receivable with a supplier for $10.0 million, which is included in other long-term assets on the consolidated balance sheet. Repayments of $2.0 million per year are due annually by March 31, in years 2024 through 2027, provided that certain production utilization targets for the prior year are met.
Accrued price protection liability consists of the following activity:
Accrued expenses and other current liabilities consist of the following:
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef